Inhibitors of the renin-angiotensin system in diabetic patients with heart failure with preserved ejection fraction treatment: impact of m235t polymorphism of angiotensinogen
Event: ESC Congress 2019
Topic: Pharmacotherapy
Session: Novelties in pathophysiology of heart failure with preserved ejection fraction
M235T polymorphism of ATG: prognostic marker of cardiovascular events in diabetic patients with heart failure with preserved ejection fraction, a 2 year follow-up.
Event: ESC Congress 2018
Topic: Epidemiology, Prognosis, Outcome
Session: Chronic heart failure – Epidemiology, prognosis, outcome
Association of M235T polymorphism of angiotensinogen gene and lipid parameters in heart failure patients with type 2 diabetes mellitus.
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure
Topic: Metabolism / Diabetes mellitus
Session: Basic science - Gene and cell therapy - Cytokines and inflammation - Molecular biology - Genetics
